Strafford will be offering a webinar/teleconference entitled "Inducement to Infringe in Hatch-Waxman Litigation: Strategies for Patent Drafting, Prosecution and Litigation" on August 21, 2014 from 1:00 to 2:30 pm (EDT). David P. Frazier, Ph.D., Thomas L. Irving, and Robert F. Shaffer of Finnegan Henderson Farabow Garrett & Dunner will provide patent counsel with guidance on claim and label language; to proactively coordinate patent, regulatory and clinical personnel; and to maintain consistency between claims and likely or actual label language throughout patent prosecution and label negotiation with the FDA. The webinar will review the following questions:
• What can be learned from the AstraZeneca v. Apotex, Bayer Schering v. Lupin, and Commil USA v. Cisco Systems Inc. decisions?
• What are the best approaches to maintain consistency between claims and likely or actual label language?
• What steps can be taken to maintain the coordination of patent, regulatory and clinical personnel throughout the patent prosecution and label negotiation with the FDA?
The registration fee for the webinar is $297 ($362 for registration and CLE processing). Those interested in registering for the webinar, can do so here.